Wockhardt Limited has scheduled a Board of Directors meeting on May 4, 2026. The agenda includes the approval of the company’s audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Furthermore, the board will evaluate proposals for raising capital through various financial instruments, including equity shares and convertible securities, to strengthen the company’s capital structure and fund future strategic initiatives.
Upcoming Board Meeting Details
Wockhardt Limited is set to convene a meeting of its Board of Directors on Monday, May 4, 2026. The primary objective of this session is to review and finalize the company’s financial performance for the final quarter and the full fiscal year ending March 31, 2026.
Strategic Capital Raising Initiatives
In addition to reporting financial results, the board will deliberate on a comprehensive plan to raise funds. This potential capital injection is intended to be executed through various methods, including the issuance of Equity Shares and other convertible instruments. The proposed instruments under consideration include:
- Global and American Depository Receipts (GDRs and ADRs)
- Foreign Currency Convertible Bonds (FCCBs)
- Various forms of Convertible Debentures (FCDs, PCDs, OCDs, and NCDs)
- Securities convertible into equity, with or without warrants
The company plans to explore these fund-raising avenues through public or private offerings, such as qualified institutions placements or preferential allotments. Any finalized plans will be subject to subsequent shareholder approval at the ensuing Annual General Meeting.
Trading Window Update
In line with corporate governance protocols, the company’s trading window for designated persons has been restricted since April 1, 2026. This closure will remain in effect until 48 hours following the official declaration of the financial results to ensure transparency and compliance with market standards.
Source: BSE
